Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)

NCT02121899 · clinicaltrials.gov ↗

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Stopped company decision to terminate

Conditions

Lung Cancer
NSCLC
NSCLC Adenocarcinoma

Sponsor

Myriad Genetic Laboratories, Inc.